Author

E. Cornillot

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:gene regulatory network inference· 3 Research Focus:cell type annotation· 2 Research Focus:chromatin & epigenetic regulation· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2

Frequent Co-Authors

C. Ben Mamoun· 3 shared P. Vydyam· 3 shared A. Sanchez-Flores· 2 shared J. Colinge· 2 shared K. Estrada· 2 shared K. G. Le Roch· 2 shared L. M. Gonzalez· 2 shared M. Alame· 2 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

C. Ben Mamoun

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

In Vitro Efficacy of Next Generation Dihydrotriazines and Biguanides Against Babesiosis and Malaria Parasites

P. Vydyam, M. Chand, S. Gihaz, I. Renard, G. D. Heffernan, L. R. Jacobus, D. P. Jacobus, K. W. Saionz, R. Shah, H.-M. Shieh, J. Terpinski, W. Zhao, E. Cornillot, C. Ben Mamoun

This study screens dihydrotriazines and biguanides against Babesia and Plasmodium parasites to identify effective antifolates with broad-spectrum activity and high therapeutic indices.

bioRxiv · Mar 20, 2024Microbiology

Multiomics analysis reveals B. MO1 as a distinct Babesia species and provides insights into its evolution and virulence.

P. Singh, P. Vydyam, T. Fang, M. Kumar, K. Estrada, R. Grande, A. Sanchez-Flores, L. M. Gonzalez, E. Montero, S. Chakravarty, S. Lonardi, V. Berry, V. Ranwez, B. Carcy, D. Depoix, , C. Ben Mamoun

The paper identifies B. MO1 as a distinct Babesia species through multiomics analysis, revealing genomic and functional differences from B. divergens and insights into their evolution and virulence.

bioRxiv · Jan 17, 2024Microbiology

Decoding The Nuclear Genome of The Human Pathogen Babesia duncani Shed Light on its Virulence, Drug Susceptibility and Evolution among Apicomplexa

S. Lonardi, P. Singh, Q. Liang, P. Vydyam, E. Khabirova, T. Fang, S. Gihaz, J. Thekkiniath, M. Munshi, S. Abel, G. Batugedara, M. Gupta, X. M. Lu, T. Lenz, S. Chakravarty, , C. Ben Mamoun

This study decodes the nuclear genome of Babesia duncani, identifies virulence factors and drug targets, and discovers potent inhibitors for treating babesiosis.

bioRxiv · May 9, 2022Microbiology

The immune landscape of primary central nervous system diffuse large B cell lymphoma

M. Alame, E. Cornillot, V. Cacheux, V. Rigau, V. Costes-Martineau, V. Lacheretz-Szablewski, J. Colinge

This study identifies three immune subtypes of PCNSL and their associations with survival and signaling pathways, suggesting immune stratification and TIM-3 as therapeutic targets.

bioRxiv · Aug 17, 2020Cancer Biology

The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities

M. Alame, E. Cornillot, V. Cacheux, G. Tosato, M. Four, L. De Oliveira, S. Gofflot, P. Delvenne, E. Turtoi, S. Cabello-Aguilar, M. Nishiyama, A. Turtoi, V. Costes Martineau, J. Colinge

This study characterizes the molecular landscape and microenvironment of salivary duct carcinoma, identifying immune checkpoints and stromal features that suggest new therapeutic strategies.

bioRxiv · Oct 21, 2019Cancer Biology